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T cells arebiased towardsrecognition of antigenpresented in the context ofmole-
cules encoded by theMHC. This is attributable to the specificity of both the clono-
typicTCR and the accessory molecules CD4 andCD8. TheCD4/CD8 phenotype
ofT cells appears to closely correlate with the class ofMHC molecule recognized
(1-7). CD4+ T cells demonstrate specificity for class II molecules, whereas CD8+
Tcells are specific for class I molecules . Various approaches have indicated thatCD8
enhances the response of class I-specific T cells (8-10), and there is now good evi-
dence to support the hypothesis that one important feature of CD8 enhancement
is a physical interaction betweenCD8 and class I (11-14). In contrast to the TCR,
which interacts with the highly polymorphic al and a2 domains ofthe class I mole-
cule, CD8 appears to function by interacting with relatively nonpolymorphic residues
within the0 domain of class 1 (15-17) .
There is a strong species preference with regard to T cell recognition ofMHC
molecules (18-23) . Thus, murine T cells recognize murine MHC molecules more
efficientlythan they recognize humanMHC molecules. For this reason, one strategy
used to analyzeMHC recognition byT cells hasbeen to examinethebasis for poor
recognition of xenogeneic MHC molecules (23) . In this report such a strategy has
been used to investigate the role of the0 domain ofclass I in T cell activation and
antigen recognition. We have compared murine CTL recognition ofthehuman class
I molecule, HLA-A2 (A2) 1 , with recognition of the A2/H-2Kb (A2/Kb ) molecule,
a chimeric form ofA2 that contains the al and a2 domains ofA2 and the 0, trans-
membrane and cytoplasmic regions of Kb . Using a series of A2-specific murine
CTL clones induced by stimulation with human cells expressing the A2 molecule,
it was observed that the majority of such CTL clones more efficiently lysed target
cells that expressed the chimeric A2/Kb molecule than target cells expressing the
native A2 molecule . Such heteroclytic recognition correlated with sensitivity to in-
hibition by anti-CD8 antibody, suggesting that enhanced recognition ofA2/Kb was
attributable to the preferential interaction of murine CD8 with the a3 domain of
a species-matched class I molecule . Further evidence supporting this view was ob-
tained by studying activation ofCTL precursors (CTLp) . Human cells bearing the
I Abbreviations used in this paper: A2, HLA-A2 ; S2m, 02-microglobulin ; CTLp, CTL precursor ; Kb ,
H-2Kb .
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A2/Kb molecule, but not human cells bearing the A2 molecule, were able to stimu-
late an A2-specific response. These results suggest that murine CD8 preferentially
interacts with the 0 domain of a species-matched class I molecule and that the re-
duced capacity of CD8 to function across species barriers is at least in part respon-
sible for poor xenoreactivity.
Materials and Methods
Animals.
￿
810.132, C57BL/6, and (C57BL/6 x B10.D2)Ft mice were obtained from the
breeding colony of the Research Institute of Scripps Clinic and were used between 6 and
20 wk of age.
Cell Lines.
￿
Human cell lines used in these studies included the A2-expressing, EBV
transformed B lymphoblastoid lines LG-2 and JY, and the A2- T cell leukemia line, Jurkat.
The murine cell lines used included the DBA/2 mastocytoma P815 (H-21) and the C57BL/6
thymoma EL4 (H-26).
Construction ofthe A2/K° Chimeric Gene.
￿
The HLA-A2.1/H-2K' gene was constructed from
a genomic clone of HLA-A2.1 (provided by Dr. Harry Orr [24]) and a genomic clone of Kb
(provided by Dr. Bruce Wallace [25]). A Hind III-Bgl II fragment of the genomic clone of
HLA-A2.1, which contained the genetic information coding for the leader sequence, al and
a2 domains of the HLA-A2.1 molecule, was ligated to a Bam HI-Barn HI fragment excised
from the Kb gene, which contained the 0, cytoplasmic, and transmembrane regions of the
Kb molecule. The A2/Kb construct was purified and ligated into the Barn HI-Hind III sites
of pSV2 .
Transfection.
￿
pSV2 plasmids containing genomic clones ofHLA-A2.1 (A2) or the chimeric
construct A2/Kb were cotransfected with the pSV2 neo plasmid containing the neomycin re-
sistance gene into each of three cell lines: P815, EL-4, and Jurkat. The Jurkat cell line was
also transfected with a pSV2 plasmid containing the neomycin resistance gene and genomic
Kb. Transfection was accomplished by electroporation using an X-Cell 450 transfection ap-
paratus (Promega Biotec, Madison, WI), with a 50-msec discharge, constant voltage (400
mV), and capacitors charged to 800 mfd (EL4), 1,000 mfd (P815), or 1,450 mfd (Jurkat).
For electroporation, 10' cells in 1 ml of PBS were mixed with 10 14g of plasmid containing
the appropriate class I gene and with 2 Rg of pSV2 neo plasmid in a 1-ml cuvette. Selection
was initiated after 24 h by addition of 400,ug/ml ofG418 (Gibco Laboratories, Grand Island,
NY) for EL-4 and P815, and 800 ug/ml of G418 for Jurkat cells. Neomycin-resistant cells
were subcloned and tested for cell surface expression of either A2 or A2/Kb by flow cytom-
etry. Transfected cell lines were maintained in the presence of250 P.g/ml ofG418 and periodi-
cally screened by flow cytometry to ensure stable expression of A2 or A2/Kb.
Detection ofA2, A2/K°, or H-2 by Flow Cytometry.
￿
Expression of A2, A2Kb, and H-2 was
detected using the A2-specific mAbs BB7.2 (26) or MA2.1 (27), the H-2131-specific mAb 34-
2-12S (28), or the H-2136-specific mAb 28-14-4S (29). A biotinylated rat anti-mouse K L chain
(AMAC, Inc., Westbrook, ME) and phycoerythrin-conjugated streptavidin (Biomeda, Foster
City, CA) was used to detect cells labeled with the class I-specific antibodies. Where stated,
biotinylated mAb MA2.1 and phycoerythrin-conjugated streptavidin was used to detect ex-
pression of A2 or A2/Kb molecules.
Derivation of A2-specific CTL Clones.
￿
CTL clones specific for A2 were generated by in-
traperitoneal immunization of a (C57BL/6 x B10.D2)F, mouse with 2 x 107, .y-irradiated
(10,000 rad) LG-2 cells. Splenocytes from this primed animal (3 x 106/ml) were cultured
in 2 ml ofculture medium consisting of RPMI 1640 supplemented with 10% heat-inactivated
FCS (HyClone Laboratories, Logan, UT), 50 pM 2-ME, 2 MM L-glutamine, and 50 Wg/ml
gentamicin, with ,y-irradiated (10,000 rad) JY cells (7 .5 x 104 cells/ml) and ,y-irradiated
(3,000 rad) C57BL/6 feeder cells (3 x 106 cells/ml). Cells from such cultures were cloned
under limiting dilution conditions withJY stimulator cells and C57BL/6 feeder cells (used
at the same concentrations as described for 2-ml cultures), in 0.2 ml culture medium sup-
plemented with 10% con A-stimulated rat spleen cell supernatant (30). CTL clones were
selected from responder cell dilutions such that <30% of the wells were positive for specific
cytotoxicity of JY target cells on day 7.W
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Generation ofan In Vitro Xenoresponse.
￿
C57BL/6 spleen cells (6 x 106) were incubated with
an equal number of irradiated (3,000 rad) syngeneic spleen cells and 2 x 105 irradiated
(10,000 rad) stimulator cells (Jurkat-A2 orJurkat-A2/Kb) in 2 ml of culture medium in wells
of 24-well tissue culture plates. Cells from 12 wells were pooled on day 6, and varying dilu-
tions were assayed for lysis of EL4 transfectants expressing A2 or A2/Kb . On day 7 after
primary stimulation, secondary stimulation was performedby expandingthe contents ofeach
primary culture well into two wells (2 ml each) and restimulating with the same number
of transfected stimulators and syngeneic spleen cells as described above. CTL activity was
assessed after 6 d of incubation.
Cytotoxicity Assay.
￿
The cytotoxicity assay was performed essentially as previously described
(31). Briefly, varying numbers of effectors and 104 51Cr-labeled target cells were incubated
for 4 h at 37°C in 0.2 ml of culture medium in U-bottomed 96-well plates (Costar, Cam-
bridge, MA). Inhibition by anti-CD8 antibody was assessed by adding 20 p,l culture media
or supernatant from the anti-CD8 hybridoma 3.168 (32) to effectors 30 min before addition
of "Cr-labeled target cells. In control experiments, culture supernatants from the anti-H-
2Dd hybridoma 34-5-8S (28), the anti-H-2k hybridoma 12-2-2S (33), and the anti-CD4 hy-
bridoma GK1.5 (34) did not affect cytotoxicity. Percent specificQr release was calculated
as: 100 x (sample release - spontaneous release)/(maximum release - spontaneous release).
Results
To examine the role of the 0 domain of class I in xenorecognition by murine
CTL, the murine cell lines P815 and EL4 were transfected with the genes encoding
either the A2 or the A2/Kb molecule. Cloned cell lines expressing comparable levels
of A2 or A2/Kb were selected (Fig. 1). The level of surface expression of A2 or
A2/Kb molecules was -50% the level of expression of H-2Db molecules on the EL4
transfectants and 70% the level of expression of H-2Dd molecules on the P815 trans-
fectants (data not shown).
CTL clones specific for A2 were produced by immunizing a (C57BL/6 x
B10.D2)Fl mouse with the A2-bearing human B lymphoma, LG2, followed by in
A P815 EL4 C Jukrat
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FIGURE 1.
￿
Expression ofA2 or A2/Kb by P815 (A), EL4 (B), orjurkat (C) cell lines. Cell lines
were transfected with either the neomycin resistance gene alone (- -) or cotransfected with the
gene for A2 (----) or A2/Kb (-). Transfectants were analyzed by flow cytometry after staining
with a biotinylated preparation ofthe HLA-A2-specific mAb, MA2.1, and avidin phycoerythrin.1094
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vitro stimulationwith asecond A2-bearing B lymphoma,JY Five CTL clones were
derived from this CTL population. Thesewere determined to be A2 specific by their
capacity to lyse A2-bearing targets andthe inhibition ofthis lysis by the HLA-A2.1-
specific mAb, MA2.1 (data not shown). The A2-specific CTL clones were assessed
for their capacity to lyse murine transfectants expressing the A2 or A2/Kb gene
product (Fig. 2). Clones C9 (Fig. 2, A andD) and C2 (Fig. 2, BandE) are represen-
tative ofthespecificity offour ofthe five clones tested. Each exhibited 5-10-fold greater
recognition of A2/Kb than A2 as determined by the number of effectors required
to achieve the same level of target cell lysis. This was observed for recognition of
both P815 (Fig. 2, A-C) and EL4 (Fig. 2, D-F) transfectants, indicating that en-
hanced recognition of A2/Kb was not a property unique to a particular cell line.
One CTL clone, Dl (Fig. 2, C and F), showed comparable recognition of A2 and
A2/Kb transfectants.
To assess the role of CD8 in recognition by these A2-specific CTLclones, theeffect
ofanti-CD8 mAb on CTLlysis of P815 transfectants was examined (Fig. 3). In con-
trast to clone D1, CTL clones C2 and C9, which showed enhanced recognition of
A2/Kb, were highly susceptible to inhibition by anti-CD8 mAb. Failure to inhibit
clone Dl indicated that the antibody preparation was not nonspecifically inhibiting
CTL clones, and implied that lysis by clone Dl was CD8 independent. Inhibition
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FIGURE 2.
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A2-specific murine
CTL recognition ofP815 or EL4
cells expressing A2 or A2/Kb.
A2-specific CTL clones C9 (A
andD), C2 (B and E), and Dl
(C and F) were examined for
lysis of P815 (A-C) or EL4
(D-F) target cells transfected
with the neomycin resistance
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FIGURE 3.
￿
Inhibition of A2-specific CTL clones by anti-CD8 antibody. CTL clones C9, C2,
and D1 (A-C, respectively) were incubated with culture media (-) or with anti-CD8 mAb,
3.168, (----) for30 minbefore addition of51Cr-labeled target cells. Target cellsused were P815
cells transfected with either A2 (") or A2/Kb (/).
of clones C2 and C9, which showed enhanced recognition of A2/Kb, suggested that
a region in the 0 domain of A2/Kb was important for CD8 binding.
An alternative explanation for these results could be that murine R2-microglobu-
lin (R2m) interacts differently with A2 than A2/Kb, resulting in an unusual confor-
mation for the A2 molecule as expressed by murine cells. To examine this point
human cell transfectants were used to ensure human 02m would be available for
association with the A2 molecule. The human cell line jurkat was transfected with
plasmids containing the A2 or A2/Kb genes, and clones showing comparable levels
ofsurface expression were selected (Fig. 1 Q. jurkat transfectantswere used as targets
for lysis by clone C2 (Table I). Again, enhanced recognition was observed for trans-
fectants expressing A2/Kb. The view that 02m associates similarly with A2 and
A2/Kb is also supported by examination of the x-ray crystallographic structure of
TABLE I
Lysis ofjurkat Transfectants by A2-specific CTL Clone C2
E/T ratio Jurkat-Kb
Target cells'
Jurkat-A2 Jurkat-A2/Kb
6.0 241 55 100
2.0 8 36 86
0.67 2 19 43
0.22 1 6 29
0.07 1 1 121096
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theA2 molecule (35). All amino acid residues ofA2 reported to interact with human
02m are conserved in the A2/Kb molecule.
The preceding results suggested that one reason xenogeneic responses are much
weaker than allogeneic responses (18-22) may be related to a species-restricted
CD8-class I interaction. Unlike allogeneic responses that are readily detectable by
primary in vitro stimulation, an additional in vivo priming step is often required
to detect the much weaker xenoresponse. To examinethesignificance ofthe CD8-class
I interaction in the stimulation of primary CTL precursors specific for xenogeneic
cells, Jurkat transfectants expressing A2 or A2/Kb were compared as stimulators
ofC57BL/6 spleen cells. An in vitro primaryCTL response to A2 could not be ob-
tained using the human cell line expressing the A2 molecule (Fig. 4). In contrast,
Jurkat transfectants expressing the A2/Kbmolecule were capable of inducing an A2-
specific xenoresponse. Due to the high level of nonspecific lysis, primary cultures
were restimulated in an attempt to reveal a weak response to the A2 transfectant.
Again, only cultures stimulated with A2/Kb transfected cells demonstrated A2-
specific lysis.
Discussion
The data presented in this report indicate that a majority of A2-specific murine
CTL clones inducedby stimulation with A2-expressing human stimulator cells showed
enhanced recognition of target cells expressing the chimeric molecule A2/Kb. Fur-
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￿
Primary andsecondary in vitro
response of C57BL/6 spleen cells to Jurkat
cells transfected with either A2 or A2/Kb.
NaiveC57BL/6spleen cells were cultured for
6din vitrowith irradiatedJurkat cells trans-
fected with A2 (A) or A2/Kb (B), and re-
sponses measured by lysis of EL4 cells trans-
fected with the neomycin resistance gene alone
(0) or cotransfected with A2 (O) or A2/Kb
(p). Primary cultures were restimulated in
vitrowith thesameJurkattransfectants as ini-
tially used. (C and D represent stimulation
with A2 and A2/Kb transfectants, respec-
tively).IRWIN ET AL.
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thermore, CTL clones showing enhanced recognition of A2/Kb were sensitive to
inhibition by anti-CD8 antibody. Taken together, these data suggest that murine
CD8 interactsmore efficiently with classImolecules that contain a species-matched
0 domain.
These data are in agreement with results presented in previous reports that have
demonstrated enhanced T cell recognition ofepitopes on theal and a2 domains when
species-matched interactions between CD8 and the 0domain of class I were per-
mitted (36, 37). In thesereports, humanCTL specific forA2 demonstrated less efficient
killing of target cells expressing the A2/Kb molecule (36), while murine CTL spe-
cific for the Kb molecule showed reduced killingof target cells expressing the Kb/A2
molecule (37). In these previous studies, CTL were generated against the molecule
forwhich they showed greaterreactivity, raisingthepossibility (favored by the authors
[36]) that reduced recognition of molecules with substituted 0 domains was due
to conformational changes in theal and a2 domains. In contrast, theresultspresented
in this report utilize CTL induced to A2. Heteroclytic recognition of the chimeric
A2/Kb molecule strongly decreases the likelihood that conformational effectson the
al and a2 domains were responsible for ourfindings. Furthermore, none ofthe CTL
clones examined in this study appeared to detect conformational differences in the
al and a2 domains of A2/Kb as compared with A2.
The significance of species-specific interaction between CD8 and 0 was also ap-
parent at the level of stimulation of CTLprecursors. Whereas a murine A2-specific
primary in vitro CTL response to human cell transfectants expressing the A2/Kb
molecule was detected, no response was stimulated by the same cell type expressing
comparable levels of A2. This implies that properties ofthe 0domain are also im-
portantfor Tcell activation. It is well established that xenogeneic responsesare much
weaker than allogeneic responses(18-23). A previous studysuggested that the struc-
tural basis forpoor recognition ofhuman MHC molecules by murine Tcells derives
from an inabilityofthemurine TCR repertoire to recognize theal and a2 domains
of HLA molecules (23). No evidence was found to indicate that substitution of a
murine 0domain into a human class I molecule could alter the frequency of acti-
vation ofCTLprecursors. Thereareanumber ofimportantdifferences in experimental
protocol that could account for this reported lack of contribution of the a3 domain
to xenogeneic T cell activation. First, in the previous study, recognition of B7 and
B7/L' was compared. It is possible that, due to species polymorphism within the
0domain, either the 0domain of B7 is recognized with higher affinity than that
of A2 by murine CD8, or the 0 domain of Ld is not recognized as well by murine
CD8 as is that of Kb. Second, the previous study examined the response to HLA
class I moleculesexpressed by murine transfectants, whereas we have compared stim-
ulation by transfectants of the human cell line, Jurkat. Murine transfectants may
provide species-specific accessory interactions that obviate the need for an efficient
CD8 interaction with the class I molecule recognized by the TCR. Supporting this
conclusion we have detected weak xenogeneic CTL responsesto murine butnothuman
A2-transfected cell lines (unpublished observations). Finally, exogenously produced
IL-2 was not provided in our cultures. Perhaps the presence of high levels of IL-2
facilitates activation of CTLp, resulting in less dependence on optimal CD8-class
I interactions.
It has been argued that CD8 increases the avidity ofTcell-target cell interaction1098
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by binding to class I molecules on the target cell (11-14). Despite the expression of
high levels of endogenous murine class I molecules by A2-expressing murine tuans=
fectants, murine CTL clones preferentially recognized A2/Kb-expressing murine
transfectants. Failure of endogenous class I molecules to compensate for the appar-
ently weak interaction of CD8 with A2 is consistent with the view that for optimal
function, CD8 must interact with the same class I molecule as is recognized by the
TCR (16, 17, 38). This may be due to an increase in avidity of the TCR for the
MHC molecule by formation of a trimolecular complex with CD8, or to enhanced
signal transduction as a result of crosslinking CD8 and the TCR complex (39-41).
In a recent report, binding between cells expressing high levels of human CD8
and cells expressing high levels of class I molecules was used to monitor C138-class
I interactions (17). Salter et al . (17) reported that binding occurred between cells
expressing human CD8 and cells expressing various humanor murine class I mole-
cules. Detection of a CD8 interaction with class I molecules of a different species
is not necessarily inconsistent with the results presented in the present report for
the following reasons. First, it is possible that murine CD8 interacts less efficiently
with human class I than does human CD8 with murine class I. Second, there is
significant polymorphism within the 0domain of class I molecules that may affect
the interaction of CD8 with individual class I molecules. Finally, the binding assay
used by Salter et al. (17) utilized cells that express extraordinarily high amounts of
CD8 and class I. At such high levels it may not be possible to monitor subtle differ-
ences in affinity between CD8 and class I molecules as may exist between species.
Such an affinity difference may be more readily demonstrable in a functional assay.
Residues 227 and 245 of class I molecules have been implicated in the binding
of murine and human CD8, respectively (15-17). As murine CD8 appears to in-
teract more efficiently with A2/Kb than with A2, examination of the differences be-
tween the 0 domains of these molecules may identify other residues important for
CD8 binding. Comparison of the amino acid sequence of the 0 domains of A2
and Kb reveals three major regions of difference. These regions span residues
193-199, 219-225, and 251-256, and are found within three turns in the membrane
proximal region of the molecule. It may be predictedthat a region that demonstrates
species specificity in its interaction with CD8 would be relatively conserved within
a species, yet vary between species. Comparison of the 0 variable regions for spe-
cies conservation identifies regions spanning residues 219-225 and 251-256. Of in-
terest, residues 219-225 are spatiallycloseto residues 227 and 245, which have been
reported to be involved in CD8 binding (15-17). Future experiments will attempt
to furtherlocalize the residues that are important for CD8 interaction with class 1.
Summary
As compared with thevigorous Tcell response normally observed againstallogeneic
MHC molecules, T cells recognize xenogeneic MHC molecules poorly. To define
structural features of the MHC molecule important for such species-specific recog-
nition, HLA-A2(A2)-specific murine CTL were examined for their recognition of
transfected cell lines expressing the class I molecules A2 or A2/H-2Kb(A2/Kb).
A2/Kb is a chimeric molecule consisting of the cd and a2 domains of A2 and the
a3, transmembrane, and cytoplasmic regions of Kb. The majority of CTL clones
showed enhanced recognition oftransfected cell lines expressing this chimeric mole-IRWIN ET AL.
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cule. Enhanced recognition was shown to correlate with sensitivity ofthe CTL clones
to inhibitionby anti-CD8 antibody. These results suggested that CD8 may interact
with class I in a species-specific manner, and that suboptimal CD8 interaction with
the 0 domain of xenogeneic molecules may be an important contribution to poor
xenoreactivity. This conclusion was supported by the capacity of A2/Kb , but not
A2 human cell transfectants, to induce a primary in vitro CTL xenoresponse specific
for A2 .
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